AcquisitionsJun 12, 2026, 10:32 AM
Aspire Biopharma to Acquire Dura Driver Control Systems for $30M Cash
AI Summary
Aspire Biopharma Holdings, Inc. signed a definitive Share Purchase Agreement to acquire 100% of Dura Driver Control Systems (DCS) for $30 million in cash. This acquisition is a transformative milestone, positioning Aspire to become a diversified, high-revenue enterprise. DCS, a global automotive supplier, reported over $200 million in revenue and $22 million in Adjusted EBITDA for FY2025. The deal is expected to close in Q3 2026, subject to customary conditions including a PCAOB audit of DCS's financials.
Key Highlights
- Aspire Biopharma to acquire 100% of Dura Driver Control Systems (DCS) for $30 million cash.
- DCS reported over $200 million in revenue and $22 million in Adjusted EBITDA for FY2025 (unaudited).
- DCS holds over 310 patents and operates 11 global manufacturing facilities.
- Acquisition is expected to significantly accelerate Aspire's revenue, earnings growth, and cash flow.
- Closing is contingent on a PCAOB audit of DCS for FY2024-2025, showing at least $12M in Gross Profit minus capex.
- The transaction is expected to close in the third quarter of 2026.
- A termination fee of $3.5 million is applicable under certain conditions.
Price Impact
More from ASBP